Reviva Pharmaceuticals Files 8-K on Financials
Ticker: RVPH · Form: 8-K · Filed: Mar 31, 2025
Sentiment: neutral
Topics: financial-reporting, corporate-actions
TL;DR
REVIVA files 8-K with financial updates for March 31, 2025.
AI Summary
Reviva Pharmaceuticals Holdings, Inc. filed an 8-K on March 31, 2025, reporting on its Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits. The filing pertains to the period ending March 31, 2025. The company was formerly known as Tenzing Acquisition Corp. before changing its name on June 6, 2018.
Why It Matters
This 8-K filing provides crucial updates on Reviva Pharmaceuticals' financial condition and operations, which is essential for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate negative news or significant changes.
Key Players & Entities
- REVIVA PHARMACEUTICALS HOLDINGS, INC. (company) — Registrant
- Tenzing Acquisition Corp. (company) — Former company name
- March 31, 2025 (date) — Date of report
- June 6, 2018 (date) — Date of name change
FAQ
What is the primary purpose of this 8-K filing for Reviva Pharmaceuticals Holdings, Inc.?
The primary purpose is to report on the company's Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits.
What was Reviva Pharmaceuticals Holdings, Inc. previously named?
Reviva Pharmaceuticals Holdings, Inc. was formerly named Tenzing Acquisition Corp.
When did the company change its name from Tenzing Acquisition Corp.?
The company changed its name on June 6, 2018.
What is the fiscal year end for Reviva Pharmaceuticals Holdings, Inc.?
The fiscal year end for Reviva Pharmaceuticals Holdings, Inc. is December 31.
What is the SIC code for Reviva Pharmaceuticals Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Reviva Pharmaceuticals Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH).